Alert Burden, Calibration, and Clinical Utility in Early Sepsis Prediction: A Systematic Review of Explainable Multimodal Models
Abstract
Early sepsis prediction models often report discrimination while providing limited information about calibration, alert volume, or the number of clinically actionable warnings generated in practice. We systematically reviewed explainable multimodal sepsis prediction studies published through 2025. Database searches yielded 1,926 records, of which 74 studies met inclusion criteria. Most models combined vital signs and laboratory data; fewer incorporated clinical text or waveform information. AUROC was reported in 93% of studies, but only 38% reported calibration and 27% quantified alert burden at an operational threshold. Explanations were commonly generated using feature attribution, yet only 16 studies evaluated explanation faithfulness or stability. External validation was performed in 22% of studies and often showed lower performance than internal testing. Studies that reported decision-curve or alert-rate analyses provided a clearer picture of potential clinical utility than discrimination metrics alone. Evidence supports continued development of multimodal sepsis prediction, but deployment claims should be tempered when calibration, alert burden, and external generalisation are unreported. Standard evaluation should include these measures alongside explainability outputs.
References
1. Begum MH, Talukder SI, Ahmed MJ, Khan MFI, Azam MA. XAI-driven multimodal deep learning for early sepsis prediction in ICU. Journal of Science, Technology and Social Transformation. 2025;1(1):30-41. doi:10.64235/j62xmk30.
2. Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10:1. doi:10.1038/s41597-022-01899-x.
3. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287.
4. Wong A, Otles E, Donnelly JP, Krumm A, McCullough J, DeTroyer-Cooley O, et al. External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Intern Med. 2021;181(8):1065-1070. doi:10.1001/jamainternmed.2021.2626.
5. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565-574. doi:10.1177/0272989X06295361.
6. Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17:230. doi:10.1186/s12916-019-1466-7.
7. Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 2019;17:195. doi:10.1186/s12916-019-1426-2.
8. Guo C, Pleiss G, Sun Y, Weinberger KQ. On calibration of modern neural networks. Proc Mach Learn Res. 2017;70:1321-1330. Available from: https://proceedings.mlr.press/v70/guo17a.html
9. Kapoor S, Narayanan A. Leakage and the reproducibility crisis in machine-learning-based science. Patterns. 2023;4(9):100804. doi:10.1016/j.patter.2023.100804.
10. Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378. doi:10.1136/bmj-2023-078378.
11. Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170(1):51-58. doi:10.7326/M18-1376.
12. Riley RD, Snell KIE, Ensor J, Burke DL, Harrell FE Jr, Moons KGM, et al. Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes. Stat Med. 2019;38(7):1276-1296. doi:10.1002/sim.7992.
13. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.
14. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi:10.1186/2046-4053-4-1.
15. Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, Page MJ, et al. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews. Syst Rev. 2021;10:39. doi:10.1186/s13643-020-01542-z.
16. Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890. doi:10.1136/bmj.l6890.
17. Wilkinson MD, Dumontier M, Aalbersberg IJ, Appleton G, Axton M, Baak A, et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016;3:160018. doi:10.1038/sdata.2016.18.
18. Kottner J, Audigé L, Brorson S, Donner A, Gajewski BJ, Hróbjartsson A, et al. Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed. J Clin Epidemiol. 2011;64(1):96-106. doi:10.1016/j.jclinepi.2010.03.002.
Published
Issue
Section
License
Authors retain copyright. Articles published under the Creative Commons Attribution 4.0 International licence (CC BY 4.0) may be shared and adapted for any purpose, including commercially, provided appropriate credit is given, a link to the licence is supplied, and changes are indicated. No additional legal or technological restrictions may be imposed. Third-party material is included only where its credit line permits. Licence: https://creativecommons.org/licenses/by/4.0/. Earlier publications remain subject to their stated licence and author agreements unless the rights holder authorizes a change.